Crossmark Global Holdings Inc. Has $989,000 Stock Position in DocuSign, Inc. (NASDAQ:DOCU)

Crossmark Global Holdings Inc. lowered its position in DocuSign, Inc. (NASDAQ:DOCU) by 46.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 10,996 shares of the company’s stock after selling 9,693 shares during the period. Crossmark Global Holdings Inc.’s holdings in DocuSign were worth $989,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Modus Advisors LLC bought a new position in shares of DocuSign in the 4th quarter worth $36,000. Itau Unibanco Holding S.A. bought a new position in shares of DocuSign in the third quarter valued at $28,000. Brooklyn Investment Group acquired a new position in shares of DocuSign during the third quarter valued at about $33,000. Friedenthal Financial acquired a new position in shares of DocuSign during the fourth quarter valued at about $54,000. Finally, Reston Wealth Management LLC bought a new stake in shares of DocuSign during the third quarter worth about $47,000. Institutional investors and hedge funds own 77.64% of the company’s stock.

Insider Buying and Selling at DocuSign

In other DocuSign news, CEO Allan C. Thygesen sold 7,764 shares of the company’s stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $69.95, for a total transaction of $543,091.80. Following the sale, the chief executive officer now directly owns 107,825 shares of the company’s stock, valued at $7,542,358.75. This represents a 6.72 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of the stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $94.77, for a total transaction of $758,160.00. Following the transaction, the chief financial officer now owns 101,439 shares of the company’s stock, valued at $9,613,374.03. This represents a 7.31 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 693,537 shares of company stock worth $66,575,817 over the last ninety days. 1.66% of the stock is currently owned by company insiders.

DocuSign Trading Up 1.2 %

DocuSign stock opened at $91.60 on Friday. The business’s 50 day simple moving average is $89.51 and its 200 day simple moving average is $71.17. DocuSign, Inc. has a 12 month low of $48.70 and a 12 month high of $107.86. The company has a market cap of $18.51 billion, a price-to-earnings ratio of 18.89, a PEG ratio of 8.30 and a beta of 0.88.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Morgan Stanley lifted their price target on DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research note on Friday, December 6th. Wells Fargo & Company upped their price target on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a report on Friday, December 6th. HSBC reissued a “reduce” rating on shares of DocuSign in a research report on Friday, December 6th. Robert W. Baird upped their target price on shares of DocuSign from $59.00 to $100.00 and gave the stock a “neutral” rating in a research note on Friday, December 6th. Finally, UBS Group increased their target price on shares of DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a report on Friday, December 6th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat, DocuSign presently has an average rating of “Hold” and a consensus target price of $92.45.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.